MIRAGEN THERAPEUTICS, INC.·4/A

Sep 17, 5:31 PM ET

Rauch Lee M. 4/A

4/A · MIRAGEN THERAPEUTICS, INC. · Filed Sep 17, 2020

Insider Transaction Report

Form 4/AAmended
Period: 2020-09-13
Rauch Lee M.
DirectorPresident & CEO
Transactions
  • Award

    Stock Option (right to buy)

    2020-09-13+900,000900,000 total
    Exercise: $0.91From: 2020-10-13Exp: 2020-09-12Common Stock (900,000 underlying)
Footnotes (2)
  • [F1]This amended Form 4 is being filed to correct the date of grant and related terms.
  • [F2]Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares vest in 48 equal monthly installments beginning on October 13, 2020, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION